AbbVie Inc (ABBV) — Capital Reinvestment Ratio
AbbVie Inc (ABBV) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow ($5.22 Billion) in capital expenditures ($329.00 Million). See AbbVie Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AbbVie Inc Capital Reinvestment Ratio (2009–2025)
This chart tracks AbbVie Inc's Capital Reinvestment Ratio across 17 annual periods. Check AbbVie Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for AbbVie Inc (2009–2025)
Year-by-year Capital Reinvestment Ratio for AbbVie Inc from 2009 to 2025. For live market cap and broader valuation context, see how much is AbbVie Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | $19.03 Billion | $1.21 Billion | ▲ +23.2% |
| 2024 | 0.05x | $18.81 Billion | $974.00 Million | ▲ +52.2% |
| 2023 | 0.03x | $22.84 Billion | $777.00 Million | ▲ +22.1% |
| 2022 | 0.03x | $24.94 Billion | $695.00 Million | ▼ -19.4% |
| 2021 | 0.03x | $22.78 Billion | $787.00 Million | ▼ -23.8% |
| 2020 | 0.05x | $17.59 Billion | $798.00 Million | ▲ +9.5% |
| 2019 | 0.04x | $13.32 Billion | $552.00 Million | ▼ -12.8% |
| 2018 | 0.05x | $13.43 Billion | $638.00 Million | ▼ -10.5% |
| 2017 | 0.05x | $9.96 Billion | $529.00 Million | ▼ -21.9% |
| 2016 | 0.07x | $7.04 Billion | $479.00 Million | ▼ -3.6% |
| 2015 | 0.07x | $7.54 Billion | $532.00 Million | ▼ -59.1% |
| 2014 | 0.17x | $3.55 Billion | $612.00 Million | ▲ +120.1% |
| 2013 | 0.08x | $6.27 Billion | $491.00 Million | ▲ +49.3% |
| 2012 | 0.05x | $6.34 Billion | $333.00 Million | ▼ -7.8% |
| 2011 | 0.06x | $6.25 Billion | $355.51 Million | ▼ -36.8% |
| 2010 | 0.09x | $4.98 Billion | $448.00 Million | ▲ +54.6% |
| 2009 | 0.06x | $5.37 Billion | $312.56 Million | — |